TOMY : Consolidated financial results for the First Nine Months of the Fiscal Year Ending March 31, 2021

Translation

Notice: This English version is a translation of the original Japanese document and is only for reference purposes. In the case where any differences occur between the English version and the original Japanese version, the Japanese version will prevail.

February 9, 2021

CONSOLIDATED FINANCIAL RESULTS for the First Nine Months of the Fiscal Year Ending March 31, 2021

Company name:	TOMY COMPANY, LTD.
Listing:	First Section of the Tokyo Stock Exchange
Securities identification code:	7867
URL:	www.takaratomy.co.jp
Representative:	Kazuhiro Kojima, Representative Director, President & COO
Inquiries:	Goshiro Ito,
Head of Corporate Administrations
TEL: [phone] (from overseas)

Scheduled date to file quarterly securities report:	February 10, 2021
Scheduled date to commence dividend payments:	-
Supplementary material on quarterly financial results:	No
Quarterly financial results presentation meeting:	Yes (for institutional investors and analysts)

(in millions of yen with fractional amounts discarded, unless otherwise noted)

1. Consolidated performance for the first nine months of the fiscal year ending March 31, 2021 (From April 1, 2020 to December 31, 2020)

(1)Consolidated operating results (cumulative)

(Percentages indicate year-on-year changes.)

Net sales	Operating profit	Ordinary profit	Profit attributable to owners of parent Profit
Nine months ended December 31, 2020 December 31, 2019	Millions of yen 110,515 131,977	% (16.3) (6.8)	Millions of yen 7,872 12,202	% (35.5) (19.2)	Millions of yen 7,456 11,817	% (36.9) (21.3)	Millions of yen 5,477 6,590	% (16.9) (36.6)

(Note)

Comprehensive income

Nine months ended December 31, 2020: 3,024 million yen [(53.8)%] Nine months ended December 31, 2019: 6,542 million yen [(48.7)%]

Basic earnings per share	Diluted earnings per share
Nine months ended December 31, 2020 December 31, 2019	yen 58.14 69.12	yen 58.11 69.05

(2) Consolidated financial position

Total assets	Net assets	Equity ratio	Net assets per share
As of December 31, 2020 March 31, 2020	Millions of yen 151,647 129,253	Millions of yen 67,412 67,410	% 44.2 51.6	yen 711.98 703.07

Reference: Equity

As of December 31, 2020: 67,030 million yen

As of March 31, 2020: 66,649 million yen

2.

Cash dividends

Annual dividends
First quarter-end	Second quarter-end	Third quarter-end	Year-end	Total
Fiscal year ended March 31, 2020 Fiscal year ending March 31, 2021	yen - -	yen 15.00 7.50	yen - -	yen 15.00	yen 30.00
Fiscal year ending March 31, 2021 (Forecast)	7.50	15.00

Note:

Revisions to the cash dividend forecasts most recently announced: None

3.

Consolidated earnings forecasts for the fiscal year ending March 31, 2021

(From April 1, 2020 to March 31, 2021)

(Percentages indicate year-on-year changes.)

Net sales	Operating profit	Ordinary profit	Profit attributable to owners of parent	Basic earnings per share
Fiscal year ending March 31, 2021	Millions of yen 145,000	% (12.0)	Millions of yen 5,500	% (48.5)	Millions of yen 5,500	% (46.1)	Millions of yen 3,000	% (33.4)	yen 31.79

Note:

Revisions to the consolidated earnings forecasts most recently announced: None

*Notes

• (1) Changes in significant subsidiaries during the nine months under review (changes in specified subsidiaries resulting in the change in scope of consolidation): Yes

  Newly included: 1 company (company name: Fat Brain Holdings, LLC)

  Excluded: -

• (2) Application of specific accounting for preparing quarterly consolidated financial statements: Yes

  Note: For more details, please refer to the section of "(4) Notes Regarding Consolidated Financial Statements, (Application of specific accounting for preparing quarterly consolidated financial statements)" of "2. Consolidated Financial Statements and Significant Notes Thereto" on page 17 of the attached material.

• (3) Changes in accounting policies, changes in accounting estimates, and restatement

  • A. Changes in accounting policies due to revisions to accounting standards: None

  • B. Changes in accounting policies due to other reasons: None

  • C. Changes in accounting estimates: None

  • D. Restatement: None

• (4) Number of issued shares (common shares)

  • A. Total number of issued shares at the end of the period (including treasury shares)

    As of December 31, 2020	96,290,850 shares
    As of March 31, 2020	96,290,850 shares

  • B. Number of treasury shares at the end of the period

    As of December 31, 2020	2,143,697 shares
    As of March 31, 2020	1,493,222 shares

  • C. Average number of shares during the period (cumulative from the beginning of the fiscal year)

Nine months ended December 31, 2020	94,223,086 shares
Nine months ended December 31, 2019	95,354,766 shares

* Quarterly financial results reports are exempt from quarterly reviews conducted by certified public accountants or audit corporation.

* Proper use of earnings forecasts, and other special matters

Regarding future forecasts, please refer to "(3) Explanation of Consolidated Earnings Forecasts and Other Forward-looking Statements," under "1. Qualitative Information Regarding Consolidated Operating Results," on page 10.

A financial results presentation meeting for institutional investors and analysts will be held via telephone conference on February 9, 2021.

[Attached Material]

1. Qualitative Information Regarding Consolidated Operating Results .............................................. 5

(1) Explanation of Operating Results ................................................................................................ 5

(2) Overview of Financial Position .................................................................................................. 10

(3) Explanation of Consolidated Earnings Forecasts and Other Forward-looking Statements ........ 10

2. Consolidated Financial Statements and Significant Notes Thereto ............................................... 11

(1) Consolidated Balance Sheet ....................................................................................................... 11

(2) Consolidated Statement of Income and Consolidated Statement of Comprehensive Income ... 13

(Consolidated statement of income) .............................................................................................. 13

(Consolidated statement of comprehensive income) ..................................................................... 14

(3) Consolidated Statement of Cash Flows ...................................................................................... 15

(4) Notes Regarding Consolidated Financial Statements ................................................................ 17

(Notes regarding assumption of going concern) ............................................................................ 17

(Notes on significant changes in the amount of shareholders' equity) .......................................... 17

(Application of specific accounting for preparing quarterly consolidated financial statements) .. 17

(Additional information) ............................................................................................................... 17

(Consolidated statement of income) .............................................................................................. 18

Segment information ..................................................................................................................... 20